Search results
HC Wainwright Reaffirms “Buy” Rating for BioNTech (NASDAQ:BNTX)
ETF DAILY NEWS· 19 hours agoBioNTech (NASDAQ:BNTX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports ...
Brokerages Set BioNTech SE (NASDAQ:BNTX) PT at $120.40
ETF DAILY NEWS· 21 hours agoBioNTech SE (NASDAQ:BNTX – Get Free Report) has been assigned a consensus recommendation of “Hold” from the ten ratings firms that are currently covering the stock, Marketbeat ...
BioNTech SE (NASDAQ:BNTX) Position Reduced by Vontobel Holding Ltd.
ETF DAILY NEWS· 2 days agoVontobel Holding Ltd. trimmed its stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 33.7% during the fourth quarter, according to its most recent filing with the ...
BioNTech (NASDAQ:BNTX) Sees Strong Trading Volume
ETF DAILY NEWS· 2 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 308,533 shares were traded during mid-day trading, a decline ...
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoPfizer stock is trading at a nine-year low as the drugmaker looks for its next big break after...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 10 hours agoBiotech stocks have been on a roller-coaster ride, but have started to fade in 2024. In 2020, the...
U.S. regulators give full approval to Pfizer COVID-19 vaccine
AOL· 2 hours agoThe vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the Food and Drug Administration, which has never before had so much evidence ...
Who can get a Covid booster this spring and how can you book?
BBC via Yahoo News· 6 days agoSpring vaccinations will be available until 30 June. Which vaccine will people get? Vaccines from...
mRNA Therapeutics Market is Estimated to be USD 45.85 billion by 2031; Driven by Innovative...
Digital Journal· 7 hours agoAccording to SNS Insider, the mRNA Therapeutics market will be reaching USD 45.85 billion by 2031 and will be growing at a CAGR of 1.7% over the forecast period of 2024-2031. mRNA Therapeutics Market Market Scope The messenger ribonucleic acid (mRNA
White House says U.S. can roll out COVID boosters next week
AOL· 5 days agoWASHINGTON (Reuters) -The United States is ready to roll out COVID-19 vaccine booster shots next...